Loading stock…

Tenet Healthcare Corporation (THC) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Tenet Healthcare Corporation

THCMarket cap $21BPrice $260.6

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Runs hospitals, surgery centers, and outpatient clinics across the US, treating millions of patients each year. Its ambulatory care arm, USPI, now drives more profit than its traditional hospitals — a quiet bet that outpatient care is healthcare's future.

In Bastion Portfolios?

52W Return+30%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+4%4

Revenue Forecast

Rev CAGR (1y)+4%4

Rev CAGR (3y)+3%3

Rev CAGR (5y)+4%4

Earnings Forecast

EPS Growth Y+1-33%2

EPS Growth Y+2-5%3

EPS Growth Y+3+5%5

Quality

Margins

EBIT Margin18%7

Net Income Margin10%6

Free Cash Flow Margin14%7

Debt

Net Debt/EBITDA2.14

Efficiency

ROE53%10

ROA11%9

Earnings Stability55

GEAR+AVERAGE62

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)137

P/E Ratio (Forward 3y)126

P/BV4.53

EV Multiples

EV/EBITDA Fwd78

EV/EBIT Fwd89

Yield

Free Cash Flow Yield14.4%10

Dividend Yieldna–

Momentum

Short term

1 month return-3%6

3 month return+26%10

YTD return+31%9

Mid term

Price vs 52wHigh92%9

1 year return+34%8

Long term

3 year return+325%10

5 year return+321%10

Risk Shield

Price Risk

Beta0.95

Volatility42%4

Free Cash Flow

Free Cash Flow Margin14%7

Free Cash Flow Yield14.4%10

Quality

ROCE16%8

Earnings Stability55

Net Debt/EBITDA2.14

02Growth

Is it actually growing, and how fast?

THCTenet Healthcare

Revenue FY25$20.7B

GROWTH RATING↗

WEAK23 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%4

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+3%3

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-33%2

EPS growth, FY27E-5%3

EPS growth, FY28E+5%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 3%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 4%/yr over the last 3 years and is set to keep growing around 3%/yr.

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Growth is the weak spot here, trailing 77% of companies worldwide.

Earnings are set to fall even as revenue grows (EPS about -5%/yr vs revenue 3%/yr).

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: earnings are forecast to fall.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG96 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-3%6

3-month return+26%10

YTD return+31%9

MID & LONG-TERM▾SCORE

% of 52-week high92%9

1-year return+34%8

3-year return+325%10

5-year return+321%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +325% over three years and +321% over five, ahead of 90% of the market.

It's up 34% over the past year, now 8% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+26%) and so far this year (+31%).

WATCH

Returns sit at the market level over the past month (-3%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Tenet. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

THCTenet Healthcare

Revenue FY25$20.7B

GROWTH RATING↗

WEAK23 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%4

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+3%3

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-33%2

EPS growth, FY27E-5%3

EPS growth, FY28E+5%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 3%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 4%/yr over the last 3 years and is set to keep growing around 3%/yr.

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Growth is the weak spot here, trailing 77% of companies worldwide.

Earnings are set to fall even as revenue grows (EPS about -5%/yr vs revenue 3%/yr).

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: earnings are forecast to fall.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG96 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-3%6

3-month return+26%10

YTD return+31%9

MID & LONG-TERM▾SCORE

% of 52-week high92%9

1-year return+34%8

3-year return+325%10

5-year return+321%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +325% over three years and +321% over five, ahead of 90% of the market.

It's up 34% over the past year, now 8% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+26%) and so far this year (+31%).

WATCH

Returns sit at the market level over the past month (-3%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on Tenet. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community